2019

CATCHPOOL M, DALZIEL K, Mahardya RTK and Harvey AS. Cost-effectiveness of epileptic surgery compared with medical treatment in children with drug-resistant epilepsy. Epilepsy & Behavior 2019; 97: 253-259.

CATCHPOOL M, Ramchand J, …, KNIGHT J and GORANITIS I. A cost-effectiveness model of genetic testing and periodical clinical screening for the evaluation of families with dilated cardiomyopathy. Genetics in Medicine 2019. DOI: 10.1038/s41436-019-0582-2.

Darvall J, von Ungern-Sternberg BS, …, TRAN-DUY A, Middleton D and Leslie K. Chewing gum to treat postoperative nausea and emesis in female patients (CHEWY): rationale and design for a multicentre randomised trial. BMJ open 2019; 9: e027505.

Manley BJ, Arnolda GRB, …, HUANG L, Roberts CT, Clark TL, Fan W-Q, Fang AYW, Marshall IR, Pszczola RJ, Davis PG and Buckmaster AG. Nasal High-Flow Therapy for Newborn Infants in Special Care Nurseries. New England Journal of Medicine 2019; 380: 2031-2040. DOI: 10.1056/NEJMoa1812077.

Kent S, Becker F, Feenstra T, TRAN-DUY A, Iryna Schlackow, TEW M, … , PALMER AJ and CLARKE PM. The challenge of transparency and validation in health economic decision modelling: A view from the mountain top. PharmacoEconomics 2019.

TEW M, CLARKE P, Thursky K and DALZIEL K. Incorporating Future Medical Costs: Impact on Cost-Effectiveness Analysis in Cancer Patients. PharmacoEconomics 2019; 37: 931-941.

TRAN-DUY A, McDermott R, KNIGHT J, Hua X, Barr EL, Arabena K, PALMER A and CLARKE PM. Development and use of prediction models for classification of cardiovascular risk of remote indigenous Australians. Heart, Lung and Circulation 2019.

Singh A, Petrović-van der Deen FS, CARVALHO N, Lopez AD, BLAKELY T. Impact of tax and tobacco-free generation on health-adjusted life years in the Solomon Islands: a multistate life table simulation. Tobacco Control 2019. DOI: 10.1136/tobaccocontrol-2018-054861

CATCHPOOL M, Gold L, Grobler AC, Clifford SA, Wake M. Health-related quality of life: Population epidemiology and concordance in Australian children aged 11-12 years and their parents. BMJ Open 2019;9(suppl 3):157–64. doi: 10.1136/bmjopen-2018-022398

RIDE, J., 2019. Is socioeconomic inequality in postnatal depression an early-life root of disadvantage for children? European Journal of Health Economics 2019.

Yeo V., Dowsey M., Alguera-Lara V., RIDE J., Lancsar E., Castle D. Antipsychotic choice: understanding shared decision-making among doctors and patients. Journal of Mental Health 2019.

Kasteridis, P., RIDE, J., Gutacker, N., et al.  Association between antipsychotic polypharmacy and outcomes for people with serious mental illness in England: Evidence from linked primary and hospital care data. Psychiatric Services 2019.

DEVLIN N. All Male Panels and Other Diversity Considerations for ISPOR. Pharmacoeconomics Open 2019 (accepted 4th July).

DEVLIN N, Lorgelly P, Herdman M. Can We Really Compare and Aggregate PRO Data Between People and Settings? Implications for Multi-Country Clinical Trials and HTA. OHE Research Paper 2019. London: Office of Health Economics.

Hernandez-Villafuerte, K., Zamora, B., Feng, Y., Parkin, D., Devlin, N, Towse, A. (2019) Exploring variations in the opportunity cost cost-effectiveness threshold by clinical area: results from a feasibility study in England. OHE Research Paper 2019. London: Office of Health Economics.

Hansen P, DEVLIN N. “Multi-Criteria Decision Analysis (MCDA) in health care decision making”, In: Oxford Research Encyclopedia of Economics and Finance, Oxford University Press 2019. DOI: 10.1093/acrefore/9780190625979.013.98.

Sullivan T, Hansen P, Ombler F, Derrett S, DEVLIN N. A new tool for creating personal and social EQ-5D-5L value sets, including valuing 'dead'. Economics Discussion Paper 1903. University of Otago 2019.

CARVALHO N, Petrie D, Chen L, Salomon JA and CLARKE P. The impact of Medicare part D on income-related inequality in pharmaceutical expenditure. International Journal for Equity in Health 2019; 18:57. https://doi.org/10.1186/s12939-019-0955-9